 |
 |
| Gritting their teeth: Biolase's Q2-2012 revenues "may be impacted by accounting consequences related to the purchase of Schein's inventory of Waterlase MD Turbos, completed in April, 2012" [and pictured above]. |
| Copyright © 2021 SPIE Europe | Designed by Kestrel Web Services |
